Skip to content

Clinical trials

Ureteral Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ureteral Neoplasms Country / region: Japan Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20151
20171
20181
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
Astellas Pharma Global Development, Inc.1
Astellas Pharma Inc1
Nagoya University1
Tokushukai Medical Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ureteral Neoplasms8
Urinary Bladder Neoplasms7
Urologic Neoplasms4
Carcinoma, Non-Small-Cell Lung3
Carcinoma, Transitional Cell3
Neoplasm Metastasis3
Urethral Neoplasms3
Esophageal Neoplasms2
Ovarian Neoplasms2
Pancreatic Neoplasms2

Trials

Showing 26 to 8 of 8. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.